"10.1371_journal.pone.0025032","plos one","2011-09-22T00:00:00Z","Peter M Janiszewski; Robert Ross; Jean-Pierre Despres; Isabelle Lemieux; Gabriella Orlando; Federica Carli; Pietro Bagni; Marianna Menozzi; Stefano Zona; Giovanni Guaraldi","School of Kinesiology and Health Studies, Queen's University, Kingston, Ontario, Canada; Division of Endocrinology and Metabolism, School of Medicine, Queen's University, Kingston, Ontario, Canada; Québec Heart Institute, Hôpital Laval Research Centre, Quebec City, Quebec, Canada; Metabolic Clinic, Infectious and Tropical Disease Unit, Department of Medicine, University of Modena and Reggio Emilia, Modena, Italy","Conceived and designed the experiments: RR J-PD SZ GG. Performed the experiments: GO FC PB MM SZ GG. Analyzed the data: PMJ SZ. Wrote the paper: PMJ RR J-PD SZ IL GG.","Dr. Ross receives honoraria for lectures from scientific, educational and lay groups; receives research funding from Canadian Institutes of Health Research, Heart and Stroke foundation of Ontario, Marks Work Warehouse and Sanofi-Aventis; is a member of the Canadian Sugar Institute Advisory Board. Dr. Guaraldi has received research grants from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Boehringer-Ingelheim, Theratechnologies and Tibotec. He has received honoraria as speaker and/or advisor from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Theratechnologies, and Tibotec. Drs. Janiszewski and Zona have no conflicts to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","09","Peter M Janiszewski","PMJ",10,TRUE,4,6,2,6,TRUE,TRUE,FALSE,0,NA,FALSE
